Phreesia Joins Greenfield, MEDITECH’s Application Developer Environment

Rhea-AI Summary

Phreesia has joined MEDITECH Greenfield, a pilot program aimed at fostering app integration with MEDITECH Expanse. This collaboration will enhance patient engagement in their care by enabling API-based integration, notifying patients about preventive care gaps, and reducing barriers to access. CEO Chaim Indig emphasized the importance of interoperability in healthcare, stating this partnership will support the development of innovative solutions for MEDITECH clients. The initiative aims to set an industry standard for interoperability.

Positive

• Partnership with MEDITECH Greenfield enhances API-based integration for clients.
• Proactive notifications for patients about preventive care promote engagement.
• Aims to reduce barriers to care, improving patient access.
• Efforts to set industry standards for interoperability could enhance market position.

Negative

• None.

RALEIGH, N.C.--(BUSINESS WIRE)-- Phreesia is pleased to announce that it is now a part of MEDITECH Greenfield, a testing ground for apps that can integrate with MEDITECH Expanse. This collaboration with MEDITECH will allow Phreesia to better enable patients to take a more active role in their care.

Through the Greenfield program, Phreesia seeks to:

• Enable API-based integration between MEDITECH and Phreesia, bringing even greater value to our shared clients
• Proactively notify patients about gaps in their preventive care, and encourage them to act to close those gaps
• Reduce barriers to care for all patients
• Set an industry standard for interoperability

“As the healthcare industry continues to evolve toward greater interoperability, programs like MEDITECH Greenfield are all the more important,” said Phreesia’s CEO Chaim Indig. “We’re very excited to join Greenfield, which will help us continue to develop innovative products and solutions for MEDITECH clients that lead to improved patient experiences and outcomes, and better access to care.”

Forward-looking Statements

This press release includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, including, without limitation, our ability to realize the anticipated benefits of our collaboration with MEDITECH when expected or at all; changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our products and services; our ability to effectively manage our anticipated growth; the impact of the COVID-19 pandemic on our business; and our ability to attract, retain and cross-sell to healthcare provider clients. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including, without limitation, those more fully described in our filings with the Securities and Exchange Commission (“SEC”), including in Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended January 31, 2021, as updated by our subsequently filed Quarterly Reports on Form 10-Q, and our other SEC Filings. The forward-looking statements in this press release speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220120005241/en/

Media:

Annie Harris

aharris@phreesia.com

929-526-2611

Source: Phreesia

FAQ

What is the significance of Phreesia joining MEDITECH Greenfield?

Joining MEDITECH Greenfield allows Phreesia to improve interoperability and patient engagement through enhanced API integrations.

How does Phreesia plan to improve patient care?

Phreesia aims to notify patients about preventive care gaps and reduce barriers to access through its collaboration with MEDITECH.

What are the expected outcomes of the Phreesia and MEDITECH partnership?

The partnership is expected to set industry standards for interoperability and enhance the overall patient care experience.

What are the future plans of Phreesia after joining the MEDITECH program?

Phreesia plans to develop innovative products and solutions that improve patient experiences and outcomes.

What stock symbol represents Phreesia?

Phreesia is represented by the stock symbol 'PHR'.